Sheba and Charité Sign MOU Focusing on Strategic Scientific and Academic Cooperation
Charité, one of Europe’s largest university hospitals, and Sheba Medical Center, recognized as two of the world’s top 10 hospitals by Newsweek magazine, concluded an agreement to collaborate on strategic scientific and academic projects with an emphasis on promoting medical innovation through joint research within Sheba’s ARC (Accelerate, Redesign, Collaborate) innovation ecosystem.
“This agreement, between two leading research and innovation hubs, will facilitate the development and implementation of transformational solutions. By leveraging ARC’s global ecosystem, we can take these solutions further and achieve a global impact,” says Prof. Eyal Zimlichman, Sheba’s Chief Transformation and Innovation Officer, as well as ARC’s Founder and Director.
Besides innovation initiatives, The MOU will prioritize sharing know-how in the fields of neuroscience and radiology, mutual support in researching the effects of long COVID, as well as promoting telemedicine initiatives.
Shortly after signing the landmark agreement during this year’s Future of Health Community summit, Prof. Dr. Heyo K. Kroemer, CEO of Charité, remarked: “Charité is very pleased to become a close partner of Sheba Medical Center, which demonstrates how new technologies and collaboration with industry partners can be used to improve patient care.”
On his part, Prof. Yitshak Kreiss, Director General of Sheba Medical Center, added: “Our strategic agreement with Charité is important because we both emphasize and appreciate excellence and professionalism. Sheba’s desire to partner with leading European institutions is also crucial to strengthening the ties between Israel and Germany, especially in the realm of healthcare. We all face the same challenges, and in Charité, we found a true partner. Together, we can work to find cutting-edge solutions to enhance the future of patient care.”